Biomarker Research accepted for inclusion in SCIE
We are delighted to announce that Biomarker Research has been accepted for inclusion in Science Citation Index Expanded (SCIE), a key database of Web of Science, published by Clarivate Analytics. Starting 2020, Biomarker Research will be published in the annual Journal Citation Reports, at which point it will receive the associated journal metrics, such as Immediacy Index, Eigenfactor Score, and Journal Impact Factor.
We would like to thank everyone for supporting Biomarker Research and contributing to this success.
Aims and scope
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines.
The study of biomarkers has evolved rapidly in the advance of personalized medicine and individual health. The identification and validation of biomarkers in drug discovery/development and in disease diagnosis, treatment, prognosis, and prevention play an essential role in the genome era. With a quick turnaround time from submission to publication and online feedback from readers, Biomarker Research strives to provide fast dissemination of novel findings and new knowledge.
Annual Journal Metrics
40 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
99 days from submission to acceptance
19 days from acceptance to publication
56 Altmetric mentions
On the blog
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).